Edition:
India

OncoSec Medical Inc (ONCS.OQ)

ONCS.OQ on NASDAQ Stock Exchange Capital Market

1.80USD
10:24pm IST
Change (% chg)

$0.03 (+1.69%)
Prev Close
$1.77
Open
$1.79
Day's High
$1.82
Day's Low
$1.77
Volume
64,482
Avg. Vol
374,068
52-wk High
$2.95
52-wk Low
$0.88

Select another date:

Thu, Feb 1 2018

BRIEF-Oncosec Medical Prices $20 Mln Public Offering Of Common Stock

* SAYS PUBLIC OFFERING OF 13.3 MILLION COMMON SHARES PRICED AT $1.50PER SHARE Source text for Eikon: Further company coverage:

BRIEF-OncoSec Medical Announces Proposed Public Offering Of Common Stock

* ONCOSEC MEDICAL INCORPORATED ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-OncoSec Provides Encouraging Clinical Observations Related To Triple Negative Breast Cancer Study

* ONCOSEC PROVIDES ENCOURAGING CLINICAL OBSERVATIONS RELATED TO TRIPLE NEGATIVE BREAST CANCER STUDY Source text for Eikon: Further company coverage:

BRIEF-Oncosec Plans To Conduct A Second Clinical Trial In Triple Negative Breast Cancer In 2018​

* ONCOSEC MEDICAL INC - PLAN TO CONDUCT A SECOND CLINICAL TRIAL IN TRIPLE NEGATIVE BREAST CANCER IN 2018​

BRIEF-OncoSec Medical files for offering of up to 6.83 mln shares

* OncoSec Medical Inc files for offering of up to 6.83 million shares of co's common stock by the selling shareholders - SEC filing Source: (http://bit.ly/2hEfpJ6) Further company coverage:

BRIEF-Oncosec announces positive follow-up data from phase 2 trial of Immunopulse il-12

* Oncosec announces positive updated long-term follow-up data from phase 2 trial of Immunopulse il-12 in combination with pembrolizumab demonstrating a progression free survival rate (PFS) of 57% at 15 months in predicted anti-pd-1 non-responder melanoma p Source text for Eikon: Further company coverage:

BRIEF-Oncosec appoints Daniel O'Connor as CEO

* Oncosec appoints Daniel J. O'Connor as chief executive officer to lead next stage of growth as a fully integrated late stage development and commercial company

BRIEF-Intracoastal Capital LLC reports 7.5 pct passive stake in OncoSec Medical

* Intracoastal Capital LLC reports 7.5 pct passive stake in OncoSec Medical Inc, as of October 22, 2017‍​ Source text: [http://bit.ly/2zVkxvZ] Further company coverage:

BRIEF-OncoSec Q4 loss per share $0.28

* OncoSec announces fourth quarter and year end financial results for fiscal year 2017

BRIEF-ONCOSEC ANNOUNCES $7.1 MLN REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

* ONCOSEC ANNOUNCES $7.1 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

Select another date: